Shmulik Adler

CardioRenal Systems, Inc. has developed the only clinically validated solution to the biggest problem today in cardiac surgery and the ICU – Acute Kidney Injury. The technology was granted Breakthrough Designation by the FDA and is CE approved with growing adoption across Europe and the Middle East. The technology was granted Breakthrough Designation by the FDA and is CE approved with growing adoption across Europe and the Middle East.